QA: HERON THERAPEUTICS INC. DE in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000818033_2023_HERON_THERAPEUTICS_INC_DE.pdf

Logs

Graph

Absolute values for 0000818033, HERON THERAPEUTICS INC. DE

  xvar xval
0 AssetsCurrent 205,435,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 22,160,000
3 remainder_Assets 23,356,000
4 LiabilitiesCurrent 82,355,000
5 LiabilitiesNoncurrent 5,740,000
6 remainder_Liabilities 149,284,000
7 CostOfGoodsAndServicesSold 54,874,000
8 SellingGeneralAndAdministrativeExpense 37,437,000
9 ResearchAndDevelopmentExpense 107,506,000
10 remainder_Expenses 82,513,000
11 remainder_Revenues 107,672,000
12 remainder_NetIncome -7,366,000
13 remainder_ComprehensiveNetIncome -13,000
  yvar yval
0 Assets 250,951,000
1 Liabilities 237,379,000
2 Expenses 282,330,000
3 Revenues 107,672,000
4 StockholdersEquity 13,572,000
5 NetIncome -182,024,000
6 ComprehensiveNetIncome -182,030,500
7 BaseVar 442,855,500
8 EconomicCapitalRatio -0.650

Edgar->Model Mapping

Feature Distribution

Change over Time